dipivoxil相关论文
AIM: To investigate the efficacy and safety of combined de novo lamivudine (LAM) and adefovir dipivoxil (ADV) therapy in......
慢性乙型肝炎是我国乃至世界突出的公共卫生健康问题.抗病毒治疗是慢性乙肝治疗的主要手段,既往主要是干扰素(interferon,IFN)和拉......
【正】BACKGROUND: The recurrence of chronic hepatitis B after liver transplantation results in increased risk for graft ......
【正】BACKGROUND: Patients with decompensated hepatitis B vires (HBV)-related cirrhosis tend to have low or undetectable......
AIM:To compare efficacy of combined lamivudine(LAM)and adefovir dipivoxil(ADV)therapy with that of entecavir(ETV)monothe......
The selection of antiviral drugs for chronic hepatitis B(CHB) treatment in pregnancy is very difficult since none of the......
AIM:To investigate the loci of adefovir dipivoxil(ADV)-induced resistance in hepatitis B virus(HBV)isolates and optimize......
AIM: To evaluate urine β2-microglobulin(β2-M), retinol-binding protein(RBP) excretion, and renal impairment with adefo......
AIM: To observe the effect of response-guided add-on therapy with adefovir(ADV) and lamivudine(LAM) in cirrhotic hepatit......
AIM:To investigate the predictors of proximal kidney tubular dysfunction(PKTD)induced by adefovir dipivoxil(ADV)treatmen......
阿德福韦酯（Adefovir dipivoxil，ADV）为5＇-单磷酸脱氧腺苷（5＇-dAMP）的无环磷酸化嘌呤类核苷酸类似物，口服后在血浆或组织内迅速转化为游离A......
Impact of Lamivudine plus Adefovir therapy in chronic hepatitis B Iranian patients, resistant to Lam
AIM: To evaluate the impact of combination therapy with Lamivudine and Adefovir for treatment of chronic hepatitis B in ......
抗病毒治疗是HBV相关肝病的治疗关键已成为医学界的共识。阿德福韦酯（adefovir dipivoxil，ADV）因相对廉价、耐药率低等特点，在我国广泛......
目的：明确临床实际工作中阿德福韦酯（ADV）治疗出现病毒学突破患者基因型耐药情况并对耐药相关因素进行分析。方法收集ADV治疗出现病毒......
Observation on the effect of adefovir dipivoxil in combined with lamivudine in the treatment of hepa
Objective:To explore the effect of adefovir dipivoxil in combined with lamivudine on the liver function in patients with......
美国的生物制药公司Gilead在《新英格医学杂志》上进一步发表了其治疗慢性乙型肝炎病毒感染的，每天一次的Viread（tenofovir disoprox......
慢性乙型肝炎（Chronic hepatitis B，CHB）治疗目前可用的药物包括免疫调节剂，如干扰素-a；口服核苷/核苷酸类似物（NAs），包括拉米夫定（lamivudi......
英国NICE的指南草案推荐聚乙二醇化α-2a（peginterferon α-2a，Roch公司的Pegasys）（Ⅰ）和阿德福韦（adefovir dipivoxil，Gilead Sciences公......
We report the case of a patient treated with living donor-related liver transplantation who suffered from osteomalacia d......
